Between a commercial seminar and an academic institution

When I describe this project to professors, they nod politely. Behind the eyes, though, I can usually see the question forming: is this just another expensive seminar business? Hardly anyone asks it aloud. It deserves to be asked aloud, because the suspicion is fair. Medical education has a long history of businesses that rent a professor's title for the brochure, never check whether anyone learned anything, and optimize for ticket sales.

Let me concede the obvious first. We charge tuition, and we do marketing. I happen to think that education which cannot pay for itself cannot protect its own quality, and I see no reason to hide that opinion. It is also why our price is printed on the program page, ¥298,000 and marked provisional, instead of sitting behind a contact form.

What separates a seminar business from an academic institution is not price. It is who holds the pen. Who decides the content? Here, faculty who passed an academic review, not sponsors. Are the pass criteria public? Ours are written into the module specification before a course opens. Does anyone check whether the teaching worked? We commit to publishing participant evaluations and outcomes every year. And when something goes wrong, can faculty walk away? Every contract we sign includes an exit clause for exactly that case.

None of this is a slogan. The sponsor no-go list is on a public page. The faculty charter is in the prospectus. The list of things we have not yet decided is on the About page. If a colleague of yours is skeptical, send them those three links and let them judge the machinery rather than my prose.

If a doubt survives all of that, bring it to the thirty-minute call. A question we cannot answer is a hole in our design, and the people who find holes are the ones we most want in the room.